ZL-85 / Zenitar Biomedical - LARVOL DELTA

An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors (ChiCTR) - P1/2 | N=72 | Sponsor: The First Affiliated Hospital Of Anhui Medical University; Chengdu Zenitar Biomedical Technology Co. Ltd

New P1/2 trial • Oncology • Solid Tumor

A Clinical Study of ZL-85FA Tablets (clinicaltrials.gov) - P1/2 | N=51 | Not yet recruiting | Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd

New P1/2 trial • Breast Cancer • Ovarian Cancer • Prostate Cancer • Solid Tumor